Clinical trial Recruiting at 12 sites Observational

Re-checking embryos labeled complex or chaotic aneuploid to find transferable embryos

Official title: ESCALATE: Evaluating the Status of Complex Aneuploidy to Locate Additional Transferrable Embryos

Run by Shady Grove Fertility Reproductive Science Center · NCT07227116 · Data updated 2026-11-12

This project tries re-biopsy and genetic reanalysis of embryos labeled complex or chaotic aneuploid to see if any have normal chromosomes and could be candidates for transfer for people with such embryos.

Quick facts

Study typeObservational
SexAll
Enrollment280 (estimated)
SponsorShady Grove Fertility Reproductive Science Center
Academic / other
Locations12 sites (Margate, Florida and 11 other locations)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedApril 2026
Study endsJune 2026
Registry record updatedNovember 12, 2025
Trial IDNCT07227116 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People who have at least one embryo previously classified as complex (three or more whole-chromosome aneuploidies) or chaotic (six or more aneuploidies) on NGS-based PGT-A and who consent to re-biopsy and reanalysis are eligible.

Probably not a fit

Patients without embryos meeting the complex/chaotic criteria or whose embryos remain abnormal on reanalysis are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational protocol performs re-biopsy and next-generation sequencing PGT-A reanalysis on embryos previously reported as complex (≥3 aneuploid chromosomes) or chaotic (≥6 aneuploid chromosomes). Consent covers only the re-biopsy and genetic testing procedures and does not include consent for embryo transfer. The goal is to determine whether some embryos initially called complex or chaotic might show corrected or normal chromosomal results on repeat testing. Participants must have at least one qualifying embryo stored at a participating clinic and participation is voluntary with no impact on clinical care.

Why it matters

Potential benefit: If successful, re-biopsy and reanalysis could identify embryos initially labeled complex or chaotic that actually have normal chromosomes and might be suitable for transfer.

How similar studies have gone: There is at least one published case report of a healthy live birth after transfer of a chaotic embryo, but larger-scale evidence is very limited and the approach remains largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Having ≥ 1 embryo classified as whole chromosome chaotic or complex aneuploid of 3 or more chromosomes following preimplantation genetic testing for aneuploidy using an NGS based platform Signed informed consent

Exclusion Criteria:

* Embryos not meeting complex/chaotic criteria Patients declining consent

Where it's running

  • IVF Florida Reproductive Associates
    Margate, Florida, United States
    Recruiting
  • Shady Grove Fertility
    Atlanta, Georgia, United States
    Recruiting
  • Fertility Center of Illinois
    Highland Park, Illinois, United States
    Recruiting
  • Shady Grove Fertility
    Rockville, Maryland, United States
    Recruiting
  • Shady Grove Fertility
    Towson, Maryland, United States
    Recruiting
  • Shady Grove Fertility
    Cary, North Carolina, United States
    Recruiting
Show 6 more locations
  • Shady Grove Fertility
    Cary, North Carolina, United States
    Recruiting
  • Shady Grove Fertility
    Chesterbrook, Pennsylvania, United States
    Recruiting
  • Shady Grove Fertility
    Fairfax, Virginia, United States
    Recruiting
  • Shady Grove Fertility
    Norfolk, Virginia, United States
    Recruiting
  • Shady Grove Fertility
    Richmond, Virginia, United States
    Recruiting
  • SGFertility Chile Medicina Reproductiva
    Santiago, Santiago Metropolitan, Chile
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • When to start hormones after stopping combined birth control for planned egg freezing

    This trial tests whether taking a two-month break from combined hormonal birth control versus starting ovarian stimulation immediately affects outcomes for ovary-bearing people aged 18–40 who are planning to freeze their eggs.

    Recruiting at 2 sites Shady Grove Fertility Reproductive Science Center · Orange, Connecticut and 2 other locations · NCT07225660

  • Comparing ICSI versus conventional IVF using frozen third‑party donor sperm

    This trial tests whether injecting sperm into eggs (ICSI) or mixing eggs with frozen donor sperm (conventional IVF) makes more and better embryos for people using frozen donor sperm without male‑factor infertility.

    Recruiting Shady Grove Fertility Reproductive Science Center · Rockville, Maryland · NCT07175571

  • Evaluating Testicular Imaging for Azoospermia Diagnosis

    This study is testing if a special type of ultrasound can help doctors see differences in the tiny tubes in the testicles of men with no sperm and help figure out why that’s happening.

    Recruiting at 2 sites Shady Grove Fertility Reproductive Science Center · Rockville, Maryland and 1 other locations · NCT06941922

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.